Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19.

Andrea Mario BollaCristian LoretelliLaura MontefuscoGiovanna FinziReza AbdiMoufida Ben NasrMaria Elena LunatiIda PastoreJoseph V BonventreManuela NebuloniStefano RusconiPierachille SantusGianvincenzo ZuccottiMassimo GalliFrancesca D'AddioPaolo Fiorina

Published in: Diabetes/metabolism research and reviews (2022)

This may support the hypothesis that diabetes and COVID-19 meet at the crossroads of inflammation and vascular dysfunction. (ClinicalTrials.gov NCT04463849 and NCT04382794).

Keyphrases

oxidative stress
coronavirus disease
sars cov
type diabetes
cardiovascular disease
glycemic control
respiratory syndrome coronavirus
metabolic syndrome
insulin resistance
drug delivery
skeletal muscle